Adamis Pharmaceuticals Corporation
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's specialty pharmaceutical product candidates comprise Symjepi (epinephrine) Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis. It also offers dry powder inhaler products consisting of fluticasone (APC-4000) for the treatment of asthma; beclomethasone (APC-1000), a metered dose inhaler product for the asthma; Tadalafil (APC-8000) for the treatment of erectile dysfunction; and naloxone injection product candidates (APC-6000) for the treatment of opioid overdose. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and certain veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation is headquartered in San Diego, California. Show More...
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 0.49 USD
-
Last Updated 09-11-2023
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-03 2011-03 2012-03 2013-03 2014-03 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -3.91 -1.87 -1.02 -1.23 -1.22 -1.03 -1.19 -0.9 -1.0 -0.55 -0.51 Dividends USD Payout Ratio % * Shares Mil 2.0 4.0 5.0 6.0 7.0 13.0 18.0 28.0 39.0 53.0 58.0 Book Value Per Share * USD 0.92 1.12 1.38 1.22 0.65 0.45 Free Cash Flow Per Share * USD -1.39 -1.3 -0.58 -0.82 -0.65 Return on Assets % -579.28 -516.68 -105.42 -108.75 -83.5 -57.27 -71.08 -55.19 -62.68 Financial Leverage (Average) 1.24 1.29 1.49 1.3 1.25 1.33 1.36 Return on Equity % -207.53 -144.25 -120.32 -78.79 -90.46 -70.85 -84.1 Return on Invested Capital % 9.94 -144.25 -83.6 -65.75 -85.63 -64.59 -75.49 Interest Coverage -1.41 -8.38 -136.06 -2.03 0.05 -111.0 -110.89 -248.59 -236.7 -222.1 Current Ratio 0.13 0.49 0.010 0.07 1.85 1.51 0.82 2.44 2.23 1.36 1.45 Quick Ratio 0.06 0.4 1.84 1.49 0.57 2.07 1.77 1.05 1.11 Debt/Equity 0.12 0.07 0.04 0.04